Henry Rosevear, MD
Dr. Rosevear, a member of the Urology Times Clinical Practice Board, is in private practice at Pikes Peak Urology, Colorado Springs, CO.
Taking the boards: Not a bad rite of passage after all
Dr. Rosevear shares his insights in taking the boards. "As far as rites of passage go, taking the urology boards turned out to be relatively benign. There were no hot coals involved. Read more.
PSA testing: It's not your choice, it's the patient’s
The use of PSA is not straightforward. It’s not simple or easy. But the last time I checked, we physicians went to school for a long time so that we could explain complicated problems to our patients.
Drug reps: Understanding the hand that feeds you
In this blog post, Dr. Henry Rosevear ponders the relationship between drug reps and urologists.
Falls in the elderly: How urologists can save a life
Read and learn from Henry Rosevear, MD who experienced first hand how falls in the elderly are common and serious.
Attention thought leaders: How is new-onset flank pain evaluated?
In this blog post, Henry Rosevear, MD, challenges thought leaders to offer guidance on the proper radiographic evaluation of new-onset colicky flank pain.
Online reputation management: Lessons from ‘Googling’ myself
Have you ever “Googled” yourself? If you haven't, try it. The results may surprise you. Simply type your name into Google or another search engine, hit search, and see what pops up. Not all of it is pretty.
Lessons learned after a year in urology’s ‘real world’
I was driving home from the office last week and realized that I have now been in the "real world" for over a year. As I looked back on the last year, I thought I would share a few of the lessons I've learned as I am curious if others have had a similar experience during their transition from residency to private practice.
Clinical hypogonadism and the urologist’s role: Primum non nocere
I consider urology to be a very unique field, one that I am lucky to be part of. Recently, though, I have begun to wonder whether the medical community (not necessarily the urology community) has been too quick to embrace the widespread use of testosterone replacement therapy.
The great prostate cancer ‘hoax’: A call to arms
Prostate cancer will not go away if we simply stop looking for it.
The Affordable Care Act: A urologist’s survival guide
In his latest blog post, Henry Rosevear, MD, summarizes the Affordable Care Act and explains how it has already affected his practice.